Keywords
diabetes
epidemiology
blood glucose
HbA1c
How to Cite
Abstract
Diabetes is a chronic disease characterized by the presence of permanent hyperglycemia. Glycated
Hemoglobin (HbA1c) is formed through the non-enzymatic binding of hemoglobin and glucose. Its
dosage in blood is one of the most relevant factors in the evaluation of the glycemic control. The aim
of this study is to correlate age, glycemic and lipid profiles in a sample of 776 patients diagnosed with
Diabetes Mellitus (DM), from a laboratory in southern Brazil. A total of 776 medical records were
analyzed between January and March 2018, and the records were obtained from the records of the
months between March 2016 and March 2018. HbA1c, glucose, triglyceride, total cholesterol, LDLcholesterol
and HDL-cholesterol values were analyzed. Our results show a predominance of elderly
women (61%), with no age variation between genders, in both it was possible to observe negative and
significant correlation between age and LDL-C. There was no clear association between HbA1c and
lipid profile. The results showed increased levels of HbA1c and a reduction in total cholesterol and
LDL-C in patients over 60 years. A strong positive correlation was found between HbA1c and glucose
parameters in both genders. The correlations between age and other variables were weak between both.
References
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37 (Suppl 1):S81-90. http://dx.doi.org/10.2337/dc14-S081
2. International Diabetes Federation 2017. [acesso 2018 Jun 16]. Disponível em: https://www.idf.org
3. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2017;40(Suppl 1):S11-24. http://dx.doi.org/ 10.2337/dc17-S005
4. Diretrizes da Sociedade Brasileira de Diabetes 2017-2018. Oliveira, JEP, Montenegro Junior R, Vencio S, Organizadores. São Paulo: Editora Clannad; 2017 [acesso 2018 Jun 18]. Disponível em: https://www.diabetes.org.br/profissionais/images/2017/diretrizes/diretrizes-sbd-2017-2018.pdf
5. Agência Brasil - Brasília (BR). Número de brasileiros com diabetes cresceu 61,8% em 10 anos. [acesso 2018 Jun10]. Disponível em: http://agenciabrasil.ebc.com.br/geral/noticia/2017-04/pesquisa-revela-quediabetes-no-brasil-cresceu-618-em-dez-anos
6. Bem A F, Kunde J. A importância da determinação da hemoglobina glicada no monitoramento das complicações crônicas do diabetes mellitus. J Bras Patol Med Lab. 2006;42(3):185-91. http://dx.doi.org/10.1590/S1676-24442006000300007
7. Netto AP, Andriolo A, Filho FF, Tambascia M, Gomes MB, Melo M et al. Atualização sobre hemoglobina glicada (HbA1C) para avaliação do controle glicêmico e para o diagnóstico do diabetes: aspectos clínicos e laboratoriais. J Bras Patol Med Lab. 2009;45(1):31-48. http://dx.doi.org/10.1590/S1676-24442009000100007
8. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–34. https://doi.org/10.2337/dc09-9033
9. Roberts WL, Safa-Pour S, De BK, Rohlfing CL, Weykamp CW, Little RR. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem 2005;51(4):776-8. https://doi. org/10.1373/clinchem.2004.047142
10. Pani L N, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care. 2008; 31(10):1991–6. https://doi.org/10.2337/dc08-0577
11. Magalhães MEC. Novas Metas de Colesterol da Diretriz de Dislipidemia da SBC. Int J Cardiovasc Sci. 2017;30(6):466-8. https://doi.org/10.5935/2359-4802.20170090
12. Davidson MB. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009; 32(2):370-2. https://doi.org/10.2337/dc08-2046
13. Instituto Brasileiro de Geografia e Estatística-IBGE. Estatística de gênero. [acesso 2019 Dez 22] . Disponível em: https:// biblioteca.ibge.gov.br/visualizacao/livros/liv101551_informativo.pdf
14. Silva AB, Engroff P, Sgnaolin V, Ely LS, Gomes I. Prevalência de diabetes mellitus e adesão medicamentosa em idosos da Estratégia Saúde da Família de Porto Alegre/RS. Cad Saúde Colet. 2016; 24(3):308-16. https://doi.org/10.1590/1414-462x201600030017
15. Silva RCP, Simões, MJS, Leite, AA. Fatores de risco para doenças cardiovasculares em idosos com diabetes mellitus tipo 2. Rev Ciên Farm Básica Apl. 2009;28(1):113-21.
16. Pazze L, Guimarâes RAB, Pimenta RGE, Paiva SLS, Bueno H, Faria TA. Perfil dos pacientes diabéticos da unidade básica de saúde do Santana-Paracatu - MG. [Monografia]. Paracatu (MG): Faculdade Atenas; 2014.
17. Palmeira CS, Pinto SR. Perfil epidemiológico de pacientes com diabetes mellitus em Salvador, Bahia, Brasil (2002-2012). Rev Baiana Enferm. 2005; 29(3): 240-9. http://dx.doi.org/10.18471/rbe.v29i3.13158
18. Instituto Brasileiro de Geografia e Estatística - IBGE. Agência de Notícias IBGE. Número de idosos cresce 18% em 5 anos e ultrapassa 30 milhões em 2017. [acesso 2018 Jun18] . Disponível em: https://
agenciadenoticias.ibge.gov.br/agencia-noticias/2012-agencia-de-noticias/noticias/20980-numero-deidosos-cresce-18-em-5-anos-e-ultrapassa-30-milhoes-em-2017.html
19. Filho ACAA, Almeida PD, Araújo AKL, Sales IMM, Araújo TME et al. Perfil epidemiológico do Diabetes Mellitus em um estado do nordeste brasileiro. Rev Fund Care. 2017 9(3):641-7. [acesso 2018 Jun 15]. Disponível em: https://www.redalyc.org/pdf/5057/505754116006.pdf
20. Barbosa JB, dos Santos AM, Barbosa MM, Barbosa MM, de Carvalho CA, Fonseca PCA et al. Síndrome metabólica, resistência insulínica e outros fatores de risco cardiovascular em universitários. Ciênc Saúde Coletiva, 2016; 21(4):1123-36. http://dx.doi.org/10.1590/1413-81232015214.10472015
21. Berlese DB, da Silva LC, dos Santos GA, da Cunha GL, Berlese DB, Feksa LR et al. Perfil sociodemográfico, bioquímico e hematológico de idosos residentes do município de Ivoti/RS. Rev Conhecimento Online, 2018;1:120-7. https://doi.org/10.25112/rco.v1i0.1145
22. de Oliveira Alvim R, Mourao-Junior, CA, Magalhaes GL, de Oliveira CM, Krieger JE, Mill JG et al. Non-HDL cholesterol is a good predictor of the risk of increased arterial stiffness in postmenopausal women in an urban Brazilian population. Clinics (Sao Paulo). 2017;72(2):106-10. http://dx.doi.org/10.6061/clinics/2017(02)07
23. Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA. Hemoglobin A1C targets for glycemic control with pharmacologic therapy for nonpregnant adults with Type 2 Diabetes Mellitus: a guidance statement update from the American College of Physicians. Ann Intern Med. 2018;168(8):569-76. https://doi.org/10.7326/M17-0939
24. Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ;2019, 366:I4894. https://doi.org/10.1136/bmj.l4894
25. Russo GT, Cosmo S, Viazzi F, Mirijello A, Ceriello A, Guida P et al. Diabetic kidney disease in the elderly: prevalence and clinical correlates. BMC Geriatr. 2018;8(1):38. https://doi.org/10.1186/s12877-018-0732-4
26. Tinsley LJ, Kupelian V, D’Eon SA, Pober D, Sun JK, King GL et al. Association of glycemic control with reduced risk for large-vessel disease after more than 50 years of type 1 diabetes. J Clin Endocrinol Metab. 2017; 102(10): 3704-11. https://doi.org/10.1210/jc.2017-00589
27. Panarotto D, Träsel HAV, de Oliveira MS, Gravina LB, Teles AR. Controle glicêmico de pacientes diabéticos tipo 2 nos serviços público e privado de Saúde. Arq Bras Endocrinol Metab. 2009;53(6):733-40. http://dx.doi.org/10.1590/S0004-27302009000600007
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Revista do Instituto Adolfo Lutz